Researchers have developed a new enzyme that prevents electron build-up in cells caused by aberrant mitochondria which could be a therapeutic technique for rare genetic conditions.
List view / Grid view
Filter the results
A mechanism has been revealed that could be used to deny RAS mutant tumour cells (which is known to encourage the growth seen in pancreatic cancer patients) of a key survival mechanism.
A new chemical tool has been used to identify hundreds of modified proteins which allows new insights to major diseases.
Researchers have used ghost imaging to enhance the imaging speed of nanoscopy, which could make it possible to capture processes in living cells at speeds not previously possible.
Researchers have developed a cell line that allows the mechanisms of prostate cancer bone metastasis to be studied in immunocompetent mice.
A new discovery that leukaemia type B cells can transform into different cells through epigenetic changes could lead to more effective therapies.
A new study has demonstrated for the first time that mutations that affect myosin motor activity result in slower cell movements in vivo.
A technique to 'trick' bacteria into revealing pores in their cell walls has been developed and targeting these could make antibiotics more effective.
A new platform has the potential to better understand what dictates the invasive behaviour of brain tumours.
A world-first compound that can keep cells alive and functioning in a healthy state could be revolutionary for medical emergencies.
Disruption of the MFF-VDAC1 complex could lead to a potential therapeutic target for cancer.
New antibiotics could be designed by discovering the mechanism a weapon bacteria uses to vanquish their competitors.
Researchers have created a new technology which enabled them to discover more about the causes of Huntington’s disease and which can be used to test drugs.
Aparajita Dubey summarises the recent trends in upstream bioprocessing and highlights the challenges and solutions involved in its process development.